NCT01874353 Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01874119 Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma Status TERMINATED Phase PHASE2
NCT01871064 Residual Curarization and Its Incidence at Tracheal Extubation in China Status COMPLETED Phase N/A
NCT01866319 Study to Evaluate the Safety and Efficacy of Two Different Dosing Schedules of Pembrolizumab (MK-3475) Compared to Ipilimumab in Participants With Advanced Melanoma (MK-3475-006/KEYNOTE-006) Status COMPLETED Phase PHASE3
NCT01866306 A Study to Evaluate the Safety and Use of Human Rhinovirus in Healthy and Asthmatic Participants (MK-0000-218) Status COMPLETED Phase PHASE1
NCT01863667 A Study to Evaluate the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus for Whom Metformin is Inappropriate (MK-3102-027) Status TERMINATED Phase PHASE3
NCT01862874 Efficacy and Tolerability Study of V501 in Japanese Males (V501-122) Status COMPLETED Phase PHASE3
NCT01860729 A Study of the Safety and Efficacy of Anacetrapib (MK-0859) Among Participants With Hypercholesterolemia When Added to Ongoing Statin Therapy (MK-0859-022) Status COMPLETED Phase PHASE3
NCT01859793 Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy Status COMPLETED Phase PHASE4
NCT01856907 Sitagliptin + Metformin Compared to Metformin Monotherapy and Placebo in Women With a Recent GDM Status COMPLETED Phase PHASE4
NCT01852942 Reversing Tissue Fibrosis to Improve Immune Reconstitution in HIV Status COMPLETED Phase PHASE2
NCT01852825 MK-8237 (SCH900237) Biomarker Study in Participants With Allergic Rhinitis or Rhinoconjunctivitis (MK-8237-009) Status COMPLETED Phase PHASE1
NCT01852604 Samatasvir (IDX719) in Combinations With Simeprevir and/or TMC647055/Ritonavir With or Without Ribavirin for 12 Weeks in Participants With Chronic Hepatitis C Infection (MK-1894-005) Status COMPLETED Phase PHASE2
NCT01852110 Efficacy and Safety of MK-7622 as Adjunct Therapy in Participants With Alzheimer's Disease (MK-7622-012) Status TERMINATED Phase PHASE2
NCT01848834 Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-012/KEYNOTE-012) Status COMPLETED Phase PHASE1
NCT01845831 Sitagliptin Therapy in Hospitalized Patients With Type 2 Diabetes Status COMPLETED Phase PHASE4
NCT01844986 Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy. Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01843868 Emesis Control Study in Non-Hodgkin Lymphoma Patients Receiving R-CHOP Status WITHDRAWN Phase NA